≡ Risteys
R8

Documentation Changelog GitHub Contact & Feedback

ILD medications: asetylcysteine

PheWeb

ILD_ASETYLCYSTEINE

No definition available.

Endpoint definition

↥
FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Medicine purchases: ATC R05CB01

1903

diagram downward connector

Check pre-conditions, main-only, mode, ICD version None

281

diagram downward connector
diagram bullet

Check minimum number of events

Min. number of events 3

281

diagram downward connector

Include endpoints None

281

diagram downward connector
ILD_ASETYLCYSTEINE

Extra metadata

First used in FinnGen datafreeze DF2

Summary Statistics

↥

Key figures

All Female Male
Number of individuals 281 105 176
Unadjusted prevalence (%) 0.08 0.05 0.11
Mean age at first event (years) 61.48 53.06 66.50

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 - - - -
15 years - - - -
5 years - - - -
1 year - - - -

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: ILD_ASETYLCYSTEINE – ILD medications: asetylcysteine
GWS hits:

Survival analyses between endpoints

↥

Plot

before ILD medications: asetylcysteine
after ILD medications: asetylcysteine

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after ILD medications: asetylcysteine

↥